Research map: Neoadjuvant chemotherapy combined with immunotherapy in selected limited-stage small-cell lung cancer: a retrospective real-world study

Back to the article

Papers in this map

  1. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) · E. A. Eisenhauer · 2008 · 30146 citations · Cited by this paper
  2. Advances in biomimetic nanomaterials for targeted drug delivery in colon cancer · 2026 · Related
  3. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries · Freddie Bray · 2024 · 26051 citations · Cited by this paper
  4. Cell-based and cell-derived strategies for anticancer therapy-related renal injury: progress, challenges, and translational perspectives · 2026 · Related
  5. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer · Leora Horn · 2018 · 3642 citations · Cited by this paper
  6. Characteristics and survival associated with pathological complete response following neoadjuvant treatment of locally advanced gastric cancer: a multicenter analysis in a real-world setting · 2026 · Related
  7. Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer · Patrick M. Forde · 2022 · 2741 citations · Cited by this paper
  8. Clinical trial design in rare mutation tumors · 2025 · Related
  9. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial · Luis G Paz-Ares · 2019 · 2314 citations · Cited by this paper
  10. Current situation and unmet demands of supportive care for cancer patients in China · 2026 · Related
  11. Small-cell lung cancer · Charles M. Rudin · 2021 · 1631 citations · Cited by this paper
  12. Review of radiotherapy combined with immune checkpoint inhibitors for microsatellite stable locally advanced rectal cancer · 2026 · Related
  13. Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer · Heather A. Wakelee · 2023 · 1148 citations · Cited by this paper
  14. Effects of resistance exercise and compression garments in the management of breast cancer-related lymphedema: a randomized controlled trial · 2026 · Related
  15. Lung cancer immunotherapy: progress, pitfalls, and promises · Aritraa Lahiri · 2023 · 1104 citations · Cited by this paper
  16. Combination of approved chemotherapeutics and natural products for topoisomerase II targeting: efficacy and safety in cancer therapy · 2025 · Related
  17. Small cell lung cancer: Where do we go from here? · Lauren A. Byers · 2014 · 651 citations · Cited by this paper
  18. Substitution mutational signatures across pan-squamous cell carcinomas · 2026 · Related
  19. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ · Anne‐Marie C. Dingemans · 2021 · 626 citations · Cited by this paper
  20. Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial · Corinne Faivre Finn · 2017 · 593 citations · Cited by this paper
  21. Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology · Apar Kishor Ganti · 2021 · 494 citations · Cited by this paper
  22. Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer · Mariano Provencio · 2023 · 483 citations · Cited by this paper
  23. New promises and challenges in the treatment of advanced non-small-cell lung cancer · May‐Lucie Meyer · 2024 · 444 citations · Cited by this paper
  24. Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial · Jie Wang · 2022 · 435 citations · Cited by this paper
  25. Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges · Giannis Mountzios · 2023 · 202 citations · Cited by this paper
  26. Association between pathologic response and survival after neoadjuvant therapy in lung cancer · Julie Stein Deutsch · 2023 · 191 citations · Cited by this paper
  27. Tislelizumab Plus Platinum and Etoposide Versus Placebo Plus Platinum and Etoposide as First-Line Treatment for Extensive-Stage SCLC (RATIONALE-312): A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 3 Clinical Trial · Ying Cheng · 2024 · 162 citations · Cited by this paper
  28. Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer · Jonathan David Spicer · 2024 · 159 citations · Cited by this paper
  29. Small-Cell Lung Cancer: Prognostic Factors and Changing Treatment Over 15 Years · Laurie E. Gaspar · 2011 · 122 citations · Cited by this paper
  30. High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538 · Jeffrey A. Bogart · 2023 · 107 citations · Cited by this paper
  31. LBA1 CheckMate 77T: Phase III study comparing neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) vs neoadjuvant placebo plus chemo followed by surgery and adjuvant NIVO or placebo for previously untreated, resectable stage II–IIIb NSCLC · Tina Cascone · 2023 · 104 citations · Cited by this paper
  32. Progress in the management of limited‐stage small cell lung cancer · Arya Amini · 2013 · 61 citations · Cited by this paper
  33. Prognosis of limited-stage small cell lung cancer with comprehensive treatment including radical resection · Lili Zhong · 2020 · 52 citations · Cited by this paper
  34. High-risk features associated with recurrence in stage I lung adenocarcinoma · Cameron N. Fick · 2024 · 47 citations · Cited by this paper
  35. LBA58 Pathological response to neoadjuvant tislelizumab (TIS) plus platinum-doublet (PtDb) chemotherapy (CT) in resectable stage II-IIIA NSCLC patients (pts) in the phase III (Ph3) RATIONALE-315 trial · Dongsheng Yue · 2023 · 39 citations · Cited by this paper
  36. SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022) · Rosario García-Campelo · 2023 · 36 citations · Cited by this paper
  37. Long-Term Outcomes After Concurrent Once- or Twice-Daily Chemoradiation in Limited-Stage Small Cell Lung Cancer: A Brief Report From the CONVERT Trial · Gerard Walls · 2024 · 34 citations · Cited by this paper
  38. Facts and Hopes on Cancer Immunotherapy for Small Cell Lung Cancer · Jon Zugazagoitia · 2024 · 28 citations · Cited by this paper
  39. Is neoadjuvant chemotherapy mandatory for limited-disease small-cell lung cancer? · Yongjie Xu · 2014 · 23 citations · Cited by this paper

Source: OpenAlex (CC0)